Market wants to verify that AHZ have their cost expenditure under control given they "were" burning through $10M+ loss per quarter. That's the only catalyst to push the pps to 20c.
Ann: SAVR Clinical Trial, page-10
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.65 |
Change
-0.350(2.92%) |
Mkt cap ! $246.2M | |||
| Open | High | Low | Value | Volume |
| $11.57 | $11.81 | $11.52 | $67.41K | 5.775K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 510 | $11.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.66 | 160 | 2 |
View Market Depth
| Last trade - 13.15pm 10/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |